Post-prostatectomy persisting PSA: Correlation with disease progression and survival in pT3 prostate cancer patients of the ARO 96-02 randomized phase III clinical trial—10 years' follow-up.
Thomas Wiegel
No relevant relationships to disclose
Detlef Bartkowiak
No relevant relationships to disclose
Dirk Bottke
No relevant relationships to disclose
Axel Hinke
No relevant relationships to disclose
Michael Stöckle
No relevant relationships to disclose
Manfred Wirth
No relevant relationships to disclose
Axel Semjonow
No relevant relationships to disclose
Kurt Miller
No relevant relationships to disclose